Arcadia Medicine

San Francisco, United States

Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.

$9.3M raised

Oct 2025

Seed

Biotechnology Mental Health Pharmaceutical Therapeutics

Top Investors

Sam Altman Dylan Field Fred Ehrsam

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Arcadia Medicine

How much funding has Arcadia Medicine raised?

Arcadia Medicine has raised $9.3M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Arcadia Medicine's investors?

Arcadia Medicine's investors include Sam Altman, Dylan Field, Fred Ehrsam.

Where is Arcadia Medicine headquartered?

Arcadia Medicine is headquartered in San Francisco, United States.

What does Arcadia Medicine do?

Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.

What stage is Arcadia Medicine at?

Arcadia Medicine is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 6, 2025.

MLA

"Arcadia Medicine — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/arcadia-medicine. Accessed July 11, 2026.

APA

VCBacked. (2025). Arcadia Medicine — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/arcadia-medicine

Wikipedia (cite web)

{{cite web |title=Arcadia Medicine — Funding & Investors |url=https://www.vcbacked.co/company/arcadia-medicine |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 6, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K